The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma
Crossref DOI link: https://doi.org/10.1007/s00262-014-1652-6
Published Online: 2015-01-22
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hughes, Tasha
Klairmont, Matthew
Broucek, Joseph
Iodice, Gail
Basu, Sanjib
Kaufman, Howard L.
Text and Data Mining valid from 2015-01-22